185 related articles for article (PubMed ID: 35621688)
1. Open Surgery including Lymphadenectomy without Adjuvant Therapy for Uterine-Confined Intermediate- and High-Risk Endometrioid Endometrial Carcinoma.
Otsuka I; Matsuura T; Mitani T; Otsuka K; Kanamoto Y
Curr Oncol; 2022 May; 29(5):3728-3737. PubMed ID: 35621688
[TBL] [Abstract][Full Text] [Related]
2. A prospective multicenter international single-arm observational study on the oncological safety of the sentinel lymph node algorithm in stage I intermediate-risk endometrial cancer (SELECT, SEntinel Lymph node Endometrial Cancer Trial).
Grassi T; Mariani A; Cibula D; Soliman PT; Suman VJ; Weaver AL; Pedra Nobre S; Weigelt B; Glaser GE; Cappuccio S; Abu-Rustum NR
Int J Gynecol Cancer; 2020 Oct; 30(10):1627-1632. PubMed ID: 32699021
[TBL] [Abstract][Full Text] [Related]
3. Survival effect of para-aortic lymphadenectomy in endometrial cancer (SEPAL study): a retrospective cohort analysis.
Todo Y; Kato H; Kaneuchi M; Watari H; Takeda M; Sakuragi N
Lancet; 2010 Apr; 375(9721):1165-72. PubMed ID: 20188410
[TBL] [Abstract][Full Text] [Related]
4. Therapeutic Benefit of Systematic Lymphadenectomy in Node-Negative Uterine-Confined Endometrioid Endometrial Carcinoma: Omission of Adjuvant Therapy.
Otsuka I
Cancers (Basel); 2022 Sep; 14(18):. PubMed ID: 36139675
[TBL] [Abstract][Full Text] [Related]
5. Long-term survival in patients with para-aortic lymph node metastasis with systematic retroperitoneal lymphadenectomy followed by adjuvant chemotherapy in endometrial carcinoma.
Hiura M; Nogawa T; Matsumoto T; Yokoyama T; Shiroyama Y; Wroblewski J
Int J Gynecol Cancer; 2010 Aug; 20(6):1000-5. PubMed ID: 20683408
[TBL] [Abstract][Full Text] [Related]
6. Should all endometrioid uterine cancer patients undergo systemic lymphadenectomy?
Wang ZQ; Wang JL; Shen DH; Li XP; Wei LH
Eur J Surg Oncol; 2013 Apr; 39(4):344-9. PubMed ID: 23333067
[TBL] [Abstract][Full Text] [Related]
7. Ultrastaging of 'negative' pelvic lymph nodes in patients with low- and intermediate-risk endometrioid endometrial cancer who developed non-vaginal recurrences.
Gill SE; Garzon S; Multinu F; Hokenstad AN; Casarin J; Cappuccio S; McGree ME; Weaver AL; Cliby WA; Keeney GL; Mariani A
Int J Gynecol Cancer; 2021 Dec; 31(12):1541-1548. PubMed ID: 34706876
[TBL] [Abstract][Full Text] [Related]
8. Role of adjuvant therapy in stage IIIC2 endometrial cancer.
Bogani G; Cappuccio S; Casarin J; Narasimhulu DMM; Cilby WA; Glaser GE; Weaver AL; McGree ME; Keeney GL; Weroha J; Petersen IA; Mariani A
Int J Gynecol Cancer; 2020 Aug; 30(8):1169-1176. PubMed ID: 32646864
[TBL] [Abstract][Full Text] [Related]
9. Lymphadenectomy as a prognostic marker in uterine non-endometrioid carcinoma.
Mylonas I; Schindlbeck C
Arch Gynecol Obstet; 2012 Jan; 285(1):207-14. PubMed ID: 21538008
[TBL] [Abstract][Full Text] [Related]
10. [Pelvic lymphadenectomy as an alternative to adjuvant radiotherapy in early stage endometrial cancer at high risk of recurrent lymphatic metastases (stage I)].
Amato NA; Partipilo V; Mele F; Boscia F; De Marzo P
Minerva Ginecol; 2009 Feb; 61(1):1-12. PubMed ID: 19204656
[TBL] [Abstract][Full Text] [Related]
11. Lymphovascular space invasion and positive pelvic lymph nodes are independent risk factors for para-aortic nodal metastasis in endometrioid endometrial cancer.
Solmaz U; Mat E; Dereli ML; Turan V; Tosun G; Dogan A; Sanci M; Ozdemir IA; Pala EE
Eur J Obstet Gynecol Reprod Biol; 2015 Mar; 186():63-7. PubMed ID: 25638600
[TBL] [Abstract][Full Text] [Related]
12. Does para-aortic lymphadenectomy improve survival in pathologically diagnosed early-stage grade 3 endometrioid and non-endometrioid endometrial cancers? A retrospective cohort study in Korea and Taiwan.
Lai YL; Chang CS; Chang K; Kim HS; Chen J; Cheng WF; Chen YL; Lee YY
Gynecol Oncol; 2022 Oct; 167(1):65-72. PubMed ID: 35995599
[TBL] [Abstract][Full Text] [Related]
13. Survival advantage of lymphadenectomy in endometrial cancer.
Eggemann H; Ignatov T; Kaiser K; Burger E; Costa SD; Ignatov A
J Cancer Res Clin Oncol; 2016 May; 142(5):1051-60. PubMed ID: 26746654
[TBL] [Abstract][Full Text] [Related]
14. Prediction of para-aortic spread by gross pelvic lymph node findings in patients with endometrial carcinoma.
Luomaranta A; Lohi J; Bützow R; Leminen A; Loukovaara M
Int J Gynecol Cancer; 2014 May; 24(4):697-702. PubMed ID: 24662132
[TBL] [Abstract][Full Text] [Related]
15. Combined pelvic and para-aortic is superior to only pelvic lymphadenectomy in intermediate and high-risk endometrial cancer: a systematic review and meta-analysis.
Petousis S; Christidis P; Margioula-Siarkou C; Papanikolaou A; Dinas K; Mavromatidis G; Guyon F; Rodolakis A; Vergote I; Kalogiannidis I
Arch Gynecol Obstet; 2020 Jul; 302(1):249-263. PubMed ID: 32468162
[TBL] [Abstract][Full Text] [Related]
16. Endometrioid adenocarcinoma of the uterus: surgico-pathological correlations and role of pelvic lymphadenectomy.
Chee JJ; Ho TH; Tay EH; Low JJ; Yam KL
Ann Acad Med Singap; 2003 Sep; 32(5):670-5. PubMed ID: 14626800
[TBL] [Abstract][Full Text] [Related]
17. Efficacy of systematic lymphadenectomy and adjuvant radiotherapy in node-positive endometrial cancer patients.
Mariani A; Dowdy SC; Cliby WA; Haddock MG; Keeney GL; Lesnick TG; Podratz KC
Gynecol Oncol; 2006 May; 101(2):200-8. PubMed ID: 16510174
[TBL] [Abstract][Full Text] [Related]
18. Prognosis for endometrial cancer patients treated with systematic pelvic and para-aortic lymphadenectomy followed by platinum-based chemotherapy.
Sueoka K; Umayahara K; Abe A; Usami T; Yamamoto A; Nomura H; Matoda M; Okamoto S; Omatsu K; Kondo E; Kato K; Takeshima N
Int J Gynecol Cancer; 2015 Jan; 25(1):81-6. PubMed ID: 25347094
[TBL] [Abstract][Full Text] [Related]
19. Survival impact based on the thoroughness of pelvic lymphadenectomy in intermediate- or high-risk groups of endometrioid-type endometrial cancer: A multi-center retrospective cohort analysis.
Kim TH; Kim HS; Kim TJ; Chang SJ; Kim DY; Ryu SY; Kim BG; Kim YT; Bae DS; Ryu HS; Nam JH
Gynecol Oncol; 2016 Jun; 141(3):440-446. PubMed ID: 27020700
[TBL] [Abstract][Full Text] [Related]
20. Survival and failure pattern of patients with endometrial cancer after extensive surgery including systematic pelvic and para-aortic lymphadenectomy followed by adjuvant chemotherapy.
Watari H; Mitamura T; Moriwaki M; Hosaka M; Ohba Y; Sudo S; Todo Y; Takeda M; Ebina Y; Sakuragi N
Int J Gynecol Cancer; 2009 Dec; 19(9):1585-90. PubMed ID: 19955942
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
